Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Amyris, Inc.    AMRS

AMYRIS, INC.

(AMRS)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector news

INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Amyris, Inc. (AMRS) on Behalf of Investors

10/26/2020 | 10:02am EST

Law Offices of Howard G. Smith announces an investigation of potential claims against the board of directors of Amyris, Inc. (“Amyris” or the “Company) (NASDAQ: AMRS) concerning whether the board breached its fiduciary duties to shareholders.

On March 19, 2019, the Company announced it was unable to file its annual report for fiscal year ending December 31, 2018 on time, due to “the significant time and resources that were devoted to the accounting for and disclosure of the significant transactions with Koninklijke DSM N.V. that closed in November 2018.” Amyris also disclosed that it was “in the process of completing its evaluation of internal control over financial reporting.”

On this news, Amyris’s share price fell $0.78, or nearly 20% to close at $3.10 per share on March 20, 2019, thereby injuring investors.

Our investigation concerns whether the Company’s board of directors breached its fiduciary duties to shareholders and/or grossly mismanaged the Company in connection with the above alleged misconduct.

If you still hold Amyris shares purchased before March 2018, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Howard G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020 by telephone at (215) 638-4847, toll-free at (888) 638-4847, or by email to howardsmith@howardsmithlaw.com, or visit our website at www.howardsmithlaw.com.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.


© Business Wire 2020
All news about AMYRIS, INC.
08:01aAMYRIS : Delivers Record Black Friday Sales
PR
11/24AMYRIS : to Present at Evercore ISI's 3rd Annual HealthCONx Conference on Decemb..
AQ
11/23AMYRIS : To Present at Evercore ISI's 3rd Annual HealthCONx Conference on Decemb..
PR
11/23AMYRIS, INC. : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, ..
AQ
11/20AMYRIS : Change in Directors or Principal Officers, Financial Statements and Exh..
AQ
11/09AMYRIS : Keeping Life Sweet, Sustainable, & Calorie-Free
PU
11/06AMYRIS : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS..
AQ
11/06AMYRIS : Reports Third Quarter 2020 Financial Results
AQ
11/05AMYRIS, INC. : Results of Operations and Financial Condition, Financial Statemen..
AQ
11/05AMYRIS, INC. : Reports Third Quarter 2020 Financial Results
PR
More news
Financials (USD)
Sales 2020 168 M - -
Net income 2020 -261 M - -
Net Debt 2020 20,0 M - -
P/E ratio 2020 -2,18x
Yield 2020 -
Capitalization 698 M 698 M -
EV / Sales 2020 4,29x
Capi. / Sales 2021 2,94x
Nbr of Employees 561
Free-Float 66,8%
Chart AMYRIS, INC.
Duration : Period :
Amyris, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends AMYRIS, INC.
Short TermMid-TermLong Term
TrendsNeutralBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 4
Average target price 6,34 $
Last Close Price 2,92 $
Spread / Highest target 277%
Spread / Average Target 117%
Spread / Lowest Target 14,7%
EPS Revisions
Managers
NameTitle
John G. Melo President, Chief Executive Officer & Director
Geoffrey Mark Duyk Chairman
Eduardo Alvarez Chief Operating Officer
Hermanus Kieftenbeld Chief Financial Officer
Sunil Chandran Senior Vice President-Research & Development
Sector and Competitors
1st jan.Capitalization (M$)
AMYRIS, INC.-5.50%698
AIR LIQUIDE9.43%77 907
SAUDI BASIC INDUSTRIES CORPORATION3.09%77 190
WANHUA CHEMICAL GROUP CO., LTD.46.16%40 039
LYONDELLBASELL INDUSTRIES N.V.-7.01%29 338
HENGLI PETROCHEMICAL CO.,LTD.60.95%27 749